Jubilant Pharmova Ltd approves Q2 and H1 FY27 results, reporting consolidated Q2 revenue of ₹2,370 crore and net profit of ₹31 crore
- Q2 revenue rose 6.3% sequentially and 20.5% year on year; net profit fell 45.0% sequentially and 74.1% year on year.
- Results included an exceptional item of ₹5.8 crore; auditors’ limited-review conclusions were unmodified.